Candesant Biomedical Patch Cleared for Excessive Underarm Sweating

The FDA has granted clearance to Candesant Biomedical’s Brella SweatControl patch to reduce excessive underarm sweating in adults with primary axillary hyperhidrosis — a condition that involves uncontrollable sweating not always related to ambient temperature or exercise.

The Brella patch is a single-use, disposable sodium sheet with an adhesive overlay that is applied by a healthcare provider and is left in place for up to three minutes. The patch uses the company’s patented alkali technology to target sweat glands and reduce sweat production.

The treatment is effective for up to four months, the company said.

The patch will be made available in select U.S. markets beginning in late summer of this year.

Related Topics